Thinking About a Clinical Trial? Here’s What Usually Happens Before You Join

Clinical trials can sound intimidating at first. Many people imagine that joining a study means saying “yes” right away, starting a new treatment immediately, or giving up control over their care.

In real life, the process is usually much slower, more careful, and more question-based than people expect.

A clinical trial is a research study involving people. Trials help researchers learn whether a medical approach may be safe, useful, or better understood. Some studies test new medicines. Others study devices, procedures, genetic testing, quality of life, symptom tracking, or long-term safety.

The important thing to know is this: finding a trial is not the same as joining a trial.

Most people go through several steps before they ever decide whether participation is right for them.

Step 1: You find a possible study

You may hear about a study from your doctor, a patient group, a hospital, a public registry, or a nonprofit navigation resource.

Official registries such as ClinicalTrials.gov include public study records with information such as recruitment status, eligibility criteria, study contacts, locations, and sometimes results.  Medical Development Group also points patients toward official directories such as ClinicalTrials.gov, Health Canada, NIH resources, WHO ICTRP, GARD, and FDA resources.

At this stage, your goal is not to decide immediately. Your goal is to collect basic information:

What condition is being studied?Where is the trial located?Is it currently recruiting?What age group is listed?What is the purpose of the study?Who can you contact for enrollment questions?

Step 2: You compare the study with your real-life situation

A trial may look relevant by diagnosis, but still may not fit your situation. For example, the study may require:

• A confirmed genetic test result.

• A certain disease stage.

• Previous treatment history.

• Specific lab results.

• Travel to a study site.

• Frequent visits.

• Time away from work, school, or caregiving duties.

This is especially important in rare disease research, where study sites may be limited and the listing may contain very technical inclusion and exclusion criteria. Medical Development Group’s site correctly highlights that rare disease trial information can be fragmented and difficult for families to interpret without plain-language orientation.

Step 3: You contact the study team

If a study seems possibly relevant, the next step is usually contacting the trial team. The contact listed in a registry record is there to answer enrollment-related questions. ClinicalTrials.gov describes study records as including contact information for people who can answer enrollment questions.

You do not need to sound like a scientist. A simple message is enough:

“Hello, I found this study and would like to understand whether it may be relevant to my diagnosis. Could you tell me what information you need from me to begin the screening process?”

Step 4: The study team checks basic fit

This is often called “pre-screening” or “screening.” The team may ask about your diagnosis, age, medical records, prior treatments, test results, medications, and location.

This does not mean you are accepted into the study. It simply helps the team decide whether a more formal review is appropriate.

Step 5: You review informed consent

Before joining, the study team must explain what participation involves. Informed consent is not just a signature. It is an educational process that should help you understand the study purpose, possible risks, possible benefits, alternatives, privacy, time commitment, and your rights. FDA guidance describes informed consent as a required process for protecting human subjects in FDA-regulated research.

You have the right to ask questions. You also have the right to take time before deciding.

Step 6: You decide with your healthcare team

A trial may be scientifically interesting but still not right for you. Your regular clinician can help you think through how trial participation might affect your current care, medications, travel burden, and monitoring needs.

Medical Development Group’s site is careful about this boundary: it provides education and navigation support, but does not give medical advice, determine eligibility, or enroll patients. Those decisions belong with qualified study teams and healthcare providers.

A helpful way to think about it

You are not “applying for treatment” in the usual sense. You are exploring whether a research study matches your medical situation, personal priorities, and practical life circumstances.

The first step is not commitment.

The first step is clarity.